DrugDevelopment

The Race for Clinical Trial Dominance: United States vs. China

A Promising Antiviral Steps Up Against Deadly Mosquito‑Borne Illnesses

AbbVie Takes the Leap: Why the $2.5 B Buy‑out of Apogee Therapeutics Could Redefine Immunology

The Great Data Divide: Navigating the Complexities of Clinical Trial Transparency

The Persistent Quest: Unpacking Concerns Around Patrick Soon-Shiong's Pancreatic Cancer Ambitions and Abivax

The Weight Loss Drug Revolution: Navigating a Fast-Evolving Market

Johnson & Johnson's Bold Bet: Steering Clear of GLP-1 Hype to Double Down on Oncology

The Dawn of Autonomous Drug Discovery: Prometheus Secures Staggering $1.2 Billion for AI-Powered Engineers

Prometheus Biosciences Secures Whopping $1.2 Billion: Unleashing the Era of 'Artificial Engineers'

Europe's Most Favored Nation Drug Pricing Push: A Looming Challenge for Innovation and Access

Boehringer Ingelheim’s Survodutide Shows Promise in Late‑Stage Obesity Trials

AstraZeneca’s CEO Says AI Is Redefining How New Medicines Are Built

BPC‑157: The Scientist Who’s Ready to Talk Skeptics

A New Chapter for Squamous Cell Lung Cancer: Harmoni’s Breakthrough at ASCO 2026

Day 2 at ASCO 2026: Fresh Data from BioNTech‑Pfizer, Kelun, Merck and Insights from Dr. Pazdur

Day 2 Highlights from ASCO 2026: Breakthroughs from BioNTech, Pfizer, Kelun, Merck and Insights by Dr. Eric Pazdur

A Glimmer of Hope: Rewriting the Future of Pancreatic Cancer Treatment

A New Dawn in Medicine: Kailera's Triple-G Drug Unveils Staggering Potential

Immunovant's Batoclimab Shakes Up Arthritis Treatment Hopes with Promising Trial Data

A Great Divide: American Biotech Grapples with the Ascendant Chinese Pharma Sector

Regenxbio's Gene Therapy Journey Hits a Couple of Bumps in the Road

REGENXBIO's Rollercoaster Ride: A Tale of Two Gene Therapies

Hantavirus Treatments Are Within Reach, Yet Funding Gaps Threaten Lifesaving Breakthroughs

The FDA's Uphill Battle: Reclaiming Trust and Scientific Rigor in a New Era

Neurocrine Biosciences: A Biotech Balancing Stable Growth with a Bold, Risky Bet

Navigating the Dragon's Den: China's Evolving Role in Global Biotech

Oncolytics Biotech: Sharpening the Focus for a Potential Breakthrough

A Paradigm Shift: CAR T-Cell Therapy Offers New Hope for Stiff Person Syndrome

A New Dawn for Pancreatic Cancer: Unpacking the Revolutionary Science from AACR 2026

A Renewed Sense of Hope: Roche's Ocrevus Continues to Impress in MS Care

Unlocking the Bacterial Front Door: A Breakthrough in Antimicrobial Research

The Audacious Pivot: How Kelonia Rose from the Brink to a $3 Billion Gene Therapy Vision

The Clock's Ticking: Harmony Biosciences, Wakix's Horizon, and the Path Ahead

A Digital Pioneer Departs: Andrew Baum's Exit from Pfizer

Lilly's Strategic Gambit: Unpacking the Kelonia Therapeutics Partnership

The Unlocking of a Legend: How Science Finally Conquered KRAS, the 'Undruggable' Cancer Foe

A Significant Setback: Arcus Biosciences Halts Key Lung Cancer Trial with Gilead

The Quest for Hair: Nektar's Rezpeg Promises a New Dawn for Alopecia Sufferers

Pharma's Next Leap: Novo Nordisk and OpenAI Forge AI Alliance